UroGen Pharma Ltd.
URGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001668243
In the last 90 days, UroGen Pharma Ltd. insiders filed 0 open-market purchases and 4 sales; 190 institutions reported holding it in 13F filings for Q2 2026, worth $1.56B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q2 2026
Institutional positions in UroGen Pharma Ltd. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 190
- +19 vs. Q1 2026
- Shares held
- 42.4M
- −4.00M (−8.6%) vs. Q1 2026
- Total value
- $1.56B
- +$725.6M (+86.9%) vs. Q1 2026
- New holders
- 40
- 61 more added
- Sold out
- 21
- 54 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting URGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 190 | $1.56B |
| Q1 2026 | 173 | $835.2M |
| Q4 2025 | 167 | $1.02B |
| Q3 2025 | 161 | $878.6M |
| Q2 2025 | 150 | $545.2M |
| Q1 2025 | 140 | $460.6M |
| Q4 2024 | 138 | $386.3M |
| Q3 2024 | 128 | $445.7M |
| Q2 2024 | 115 | $641.4M |
| Q1 2024 | 112 | $407.4M |
| Q4 2023 | 105 | $321.2M |
| Q3 2023 | 101 | $248.3M |
| Q2 2023 | 85 | $137.8M |
| Q1 2023 | 66 | $116.1M |
| Q4 2022 | 64 | $115.4M |
| Q3 2022 | 60 | $110.8M |
| Q2 2022 | 65 | $109.2M |
| Q1 2022 | 84 | $123.9M |
| Q4 2021 | 78 | $140.4M |
| Q3 2021 | 93 | $236.9M |
| Q2 2021 | 82 | $213.7M |
| Q1 2021 | 89 | $278.5M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding UroGen Pharma Ltd.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Meitav Dash Investments Ltd | 0 | $0 | 0.00% | −22,223−100.0% | Sold out |
| Kranot Hishtalmut Le Morim Tichoniim Havera Menahelet LTD | 0 | $0 | 0.00% | −21,823−100.0% | Sold out |
| Vivaldi Capital Management, LLC | 0 | $0 | 0.00% | −15,661−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −11,000−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,124−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −688−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −553−100.0% | Sold out |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Twin Peaks Wealth Advisors, LLC | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| Root Financial Partners, LLC | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| JPL Wealth Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Janus Henderson Group PLC | – | – | – | – | Not filed |
| CWM, LLC | – | – | – | – | Not filed |